Ruiqing Peng
- Topics
- Sarcoma Diagnosis and Treatment (10 papers)Vascular Tumors and Angiosarcomas (5 papers)Cancer Immunotherapy and Biomarkers (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ruiqing Peng
26 papers receiving 491 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 293
- Cancer Research 183
- Oncology 160
- Immunology 99
- Pulmonary and Respiratory Medicine 79
Countries citing papers authored by Ruiqing Peng
This map shows the geographic impact of Ruiqing Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiqing Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiqing Peng more than expected).
Fields of papers citing papers by Ruiqing Peng
This network shows the impact of papers produced by Ruiqing Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiqing Peng. The network helps show where Ruiqing Peng may publish in the future.
Co-authorship network of co-authors of Ruiqing Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Ruiqing Peng. A scholar is included among the top collaborators of Ruiqing Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiqing Peng. Ruiqing Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 17 | |
| 4 | 28 | |
| 5 | 3 | |
| 6 | 7 | |
| 7 | 18 | |
| 8 | 7 | |
| 9 | 9 | |
| 10 | 26 | |
| 11 | 46 | |
| 12 | 34 | |
| 13 | 21 | |
| 14 | 18 | |
| 15 | 149 | |
| 16 | Expression and clinical significance of high mobility group box 1 in stage IIIB colon cancer | 1 |
| 17 | Mechanism of Anoikis Resistance Mediated by PYK2 in H460 Lung Carcinoma Cells | 1 |
| 18 | 1 | |
| 19 | 54 | |
| 20 | 24 |
About Ruiqing Peng
Ruiqing Peng is a scholar working on Oncology, Biological Psychiatry and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 503 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (10 papers), Vascular Tumors and Angiosarcomas (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Biological Psychiatry (41 citations), Cancer Research (183 citations) and Oncology (160 citations). Ruiqing Peng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hua Tang, Xin Li, Haifang Li, Min Liu, Haiying Wan, Xing Zhang, Ya Ding, Xiaoshi Zhang, Jingjing Zhao and Xizhi Wen. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.